BIOCRYST PHARMACEUTICALS, INC. Income Taxes Paid
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Income Taxes Paid of $3.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-05
- BIOCRYST PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2026-06-30 was $1.63M, a 32.60% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2026-03-31 was $1.43M, a 143000.00% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2025-06-30 was $1.23M.
- BIOCRYST PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2025-03-31 was $1.00K.
- BIOCRYST PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2025 was $2.80M, a 74.86% increase from fiscal 2024.
- BIOCRYST PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2024 was $1.60M, a 11.79% increase from fiscal 2023.
- BIOCRYST PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2023 was $1.43M.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|
| 2026-06-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.06M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $1.43M 10-Q · filed 2026-05-06 | ||
| 2025-12-31 | $2.80M 10-K · filed 2026-02-26 | ||
| 2025-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.23M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $1.00K 10-Q · filed 2026-05-06 | ||
| 2024-12-31 | $1.60M 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $1.43M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |